arxada\u2019s history began in july 2021, when the investment firms bain capital and cinven finalized the acquisition of the specialty ingredients division of the lonza group. the entity, initially named lsi, was renamed arxada in october of the same year. this name, derived from the latin words arx<\/em> and arcis<\/em>\u2014meaning citadel and fortress\u2014reflects the company\u2019s mission: to protect its customers\u2019 products through microbial control technologies.<\/p>\n\n\n\n shortly after its founding, arxada rapidly expanded its portfolio by acquiring troy corporation, a specialist in performance additives, as well as enviro tech chemical services, a recognized player in biocides and disinfectants. the company has since continued its global growth through major strategic partnerships, such as an agreement signed in 2026 with clorox healthcare to develop sporicidal disinfection technology.<\/p>\n\n\n\n today, arxada serves markets as diverse as professional hygiene, paints and coatings, wood protection, home and personal care, and human health and nutrition. its mission: to help its customers design safer, more sustainable, and higher-performing products, drawing on decades of expertise in chemistry, microbiology, and biotechnology.<\/p>\n\n\n\n arxada\u2019s site in valais, which has operated as a public limited company (sa) since 2019, stands out for its dual focus on research and manufacturing. it is one of the group\u2019s seven sites that combine these two activities\u2014an asset that enables it to support its customers from concept through to industrial production, without any intermediate piloting stages.<\/p>\n\n\n\n with over 40 years of experience as a cdmo (contract development and manufacturing organization), visp specializes exclusively in the manufacture of advanced intermediates and active pharmaceutical ingredients.<\/p>\n\n\n\n the site relies on five highly flexible and interconnected multi-purpose chemical complexes, comprising a total of 22 production units and a combined reactor volume of 670 m\u00b3, enabling the processing of quantities ranging from a few grams to several metric tons.<\/p>\n\n\n\n this industrial flexibility is also underpinned by upstream integration: several key reagents, such as ketene, hydrocyanic acid, and ammonia, are produced directly on-site. visp thus masters a wide range of synthesis technologies. the site also complies with various international quality standards.<\/p>\n\n\n\n since its founding, arxada has placed sustainability at the heart of its strategy. the visp site exemplifies this ambition through a comprehensive decarbonization plan, which has led to a significant reduction in its emissions.<\/p>\n\n\n\n among the technologies implemented, vapor compression plays a key role in niacin production. its principle is similar to that of a heat pump: energy is reused and then \u201cpumped\u201d to a usable temperature level using electricity. the introduction of this system both reduces co\u2082 emissions and cuts energy consumption by a factor of ten.<\/p>\n\n\n\n headquarters<\/strong>: visp <\/p>\n\n\n\nvisp, a leading industrial and scientific site<\/strong><\/h5>\n\n\n\n
a strong commitment to decarbonization<\/strong><\/h5>\n\n\n\n
arxada\u00a0sa at a\u00a0glance<\/strong>\u00a0<\/h5>\n\n\n\n